… investigated the cause of mortality and prognostic implications of sarcopenia in patients with
… loss, indicating that sarcopenia in patients with IPF proceeded covertly. Importantly, altered …

… sarcopenia in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to investigate
the clinical characteristics of sarcopenia … Other patients with stable IPF had not received …

… patients with and without sarcopenia at follow-up. In particular, among the patients with
sarcopenia 1 received … , while among patients without sarcopenia 12 received pirfenidone, 19 …

… Multivariable analyses showed that all-cause mortality was associated with low ESM CSA (…
rate could have been overestimated because patients received intensive care. In addition, the …

… revealed that sarcopenia was a significant predictor of all-cause mortality in models 1 and
2. In … This research did not receive any specific grant from funding agencies in the public, …

… , it has received little attention in patients with idiopathic pulmonary … pulmonary disease
and idiopathic pulmonary fibrosis (IPF) (2, 3). These diseases combined with sarcopenia carries …

… patients with sarcopenia. However, little is known about the clinical impact of the PEFR in
idiopathic pulmonary fibrosis (… risk of all-cause mortality. In the present study, more than 80% of …

… significantly lower in sarcopenic patients. Lower FFMI and higher frailty scores are associated
with a greater risk of mortality in our cohort, independent of age and sex. BMI was shown …

… CSA ) can be used to evaluate sarcopenia and cachexia in patients with lung diseases. This
… in patients with idiopathic pulmonary fibrosis (IPF). Data from consecutive patients with IPF …

… between sarcopenia and higher all-cause mortality risk lacks … to sarcopenia, further
exacerbating the risk of mortality. The … regarding whether patients received pulmonary …